Ladenburg Thalmann & Co. analyst Michael Higgins maintained a Buy rating on BiomX (PHGE - Research Report) today and set a price target of $6.00. The company's shares closed yesterday at $0.33.According to TipRanks, Higgins is a 3-star analyst with an average return of 2.9% and a 28.57% success rate. Higgins covers the Healthcare sector, focusing on stocks such as Palatin Technologies, SCYNEXIS, and Eiger Biopharmaceuticals.The word on The Street in general, suggests a Moderate Buy analyst consensus rating for BiomX with a $6.00 average price target, implying a 1,746.15% upside from current levels.
https://www.tipranks.com/news/blurbs/biomx-phge-gets-a-buy-from-ladenburg-thalmann-co?utm_source=advfn.com&utm_medium=referral